14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in Lima, Peru

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Although pre‐exposure prophylaxis (PrEP) is a remarkable biomedical advance to prevent HIV, ongoing research on PrEP contributes to and interacts with a legacy of HIV experimentation on marginalized communities in resource‐limited settings. This paper explores the complexity of PrEP research mistrust among Peruvian transgender (trans) women who completed a PrEP adherence intervention and those who refused participation (i.e. declined to enrol, voluntarily withdrew, and/or were lost to follow‐up).

          Methods

          Data were derived from 86 trans women (mean age 29 years) participants in the formative (four focus groups (n = 32), 20 interviews) and the evaluation stages (34 interviews) of a social network‐based PrEP intervention for trans women in Lima, Peru. The formative stage took place from May to July 2015, while the evaluative stage took place from April to May 2018. Audio files were transcribed verbatim and analysed via an immersion crystallization approach using Dedoose (v.6.1.18).

          Results

          Three paradoxes of trans women’s participation in PrEP science as a “key” population emerged as amplifying mistrust: (1) increases in PrEP research targeting trans women but limited perceived improvements in HIV outcomes; (2) routine dismissal by research physicians and staff of PrEP‐related side effects and the social realities of taking PrEP, resulting in questions about who PrEP research is really for and (3) persistent limitations on PrEP access for trans women despite increasing involvement in clinical trials, fostering feelings of being a “guinea pig” to advance PrEP science.

          Conclusions

          Findings highlight the wisdom inherent in PrEP mistrust as a reflection of trans women’s experiences that underscore the broken bonds of trust between communities, researchers and the research enterprise. PrEP mistrust is amplified through perceived paradoxes that suggest to trans women that they are key experimental participants but not target PrEP users outside of research settings. Findings highlight the urgent need to reframe mistrust not as a characteristic of trans women to be addressed through education and outreach, but as a systemic institutional‐ and industry‐level problem replicated, manifested and ultimately to be corrected, through global HIV science.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

          Antiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition. We randomly assigned 2499 HIV-seronegative men or transgender women who have sex with men to receive a combination of two oral antiretroviral drugs, emtricitabine and tenofovir disoproxil fumarate (FTC-TDF), or placebo once daily. All subjects received HIV testing, risk-reduction counseling, condoms, and management of sexually transmitted infections. The study subjects were followed for 3324 person-years (median, 1.2 years; maximum, 2.8 years). Of these subjects, 10 were found to have been infected with HIV at enrollment, and 100 became infected during follow-up (36 in the FTC-TDF group and 64 in the placebo group), indicating a 44% reduction in the incidence of HIV (95% confidence interval, 15 to 63; P=0.005). In the FTC-TDF group, the study drug was detected in 22 of 43 of seronegative subjects (51%) and in 3 of 34 HIV-infected subjects (9%) (P<0.001). Nausea was reported more frequently during the first 4 weeks in the FTC-TDF group than in the placebo group (P<0.001). The two groups had similar rates of serious adverse events (P=0.57). Oral FTC-TDF provided protection against the acquisition of HIV infection among the subjects. Detectable blood levels strongly correlated with the prophylactic effect. (Funded by the National Institutes of Health and the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, NCT00458393.).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Aligning the goals of community-engaged research: why and how academic health centers can successfully engage with communities to improve health.

            Community engagement (CE) and community-engaged research (CEnR) are increasingly viewed as the keystone to translational medicine and improving the health of the nation. In this article, the authors seek to assist academic health centers (AHCs) in learning how to better engage with their communities and build a CEnR agenda by suggesting five steps: defining community and identifying partners, learning the etiquette of CE, building a sustainable network of CEnR researchers, recognizing that CEnR will require the development of new methodologies, and improving translation and dissemination plans. Health disparities that lead to uneven access to and quality of care as well as high costs will persist without a CEnR agenda that finds answers to both medical and public health questions. One of the biggest barriers toward a national CEnR agenda, however, are the historical structures and processes of an AHC-including the complexities of how institutional review boards operate, accounting practices and indirect funding policies, and tenure and promotion paths. Changing institutional culture starts with the leadership and commitment of top decision makers in an institution. By aligning the motivations and goals of their researchers, clinicians, and community members into a vision of a healthier population, AHC leadership will not just improve their own institutions but also improve the health of the nation-starting with improving the health of their local communities, one community at a time.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A new colonialism?--Conducting clinical trials in India.

                Bookmark

                Author and article information

                Contributors
                a.perezbrumer@utoronto.ca
                Journal
                J Int AIDS Soc
                J Int AIDS Soc
                10.1002/(ISSN)1758-2652
                JIA2
                Journal of the International AIDS Society
                John Wiley and Sons Inc. (Hoboken )
                1758-2652
                27 September 2021
                September 2021
                : 24
                : 9 ( doiID: 10.1002/jia2.v24.9 )
                : e25769
                Affiliations
                [ 1 ] Division of Social and Behavioural Health Dalla Lana School of Public Health University of Toronto Toronto ON Canada
                [ 2 ] Department of Medicine Division of Infectious Diseases Brigham and Women’s Hospital Boston MA USA
                [ 3 ] Feminas Lima Peru
                [ 4 ] Universidad Peruana Cayetano Heredia Lima Peru
                [ 5 ] Asociación Civil Impacta Salud y Educación Lima Peru
                [ 6 ] Department of Global Health University of Washington Seattle WA USA
                [ 7 ] Centro de Investigaciones Tecnologicas y Biomedicas Universidad Nacional de San Marcos Lima Peru
                [ 8 ] Harvard T.H. Chan School of Public Health Boston MA USA
                [ 9 ] The Fenway Institute Fenway Health Boston MA USA
                [ 10 ] Beth Israel Deaconess Medical Center Boston MA USA
                [ 11 ] Harvard Medical School Boston MA USA
                [ 12 ] Department of Medicine Division of Infectious Diseases University of California Los Angeles David Geffen School of Medicine Los Angeles CA USA
                Author notes
                [*] [* ] § Corresponding author: Amaya Perez‐Brumer, 155 College Street, 5th Floor, Room 554, Toronto M5T 3M7, Ontario, Canada. Tel: +1 416 978 5178. ( a.perezbrumer@ 123456utoronto.ca )

                Author information
                https://orcid.org/0000-0003-2441-4358
                https://orcid.org/0000-0001-7460-733X
                Article
                JIA225769
                10.1002/jia2.25769
                9936804
                34569152
                c88fb518-427c-410f-8875-95497bfad308
                © 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 28 May 2021
                : 22 December 2020
                : 24 June 2021
                Page count
                Figures: 0, Tables: 0, Pages: 7, Words: 6246
                Funding
                Funded by: National Institute of Health
                Award ID: R34 MH105272
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                September 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.5 mode:remove_FC converted:17.02.2023

                Infectious disease & Microbiology
                mistrust,prep,transgender,critical global health,hiv prevention
                Infectious disease & Microbiology
                mistrust, prep, transgender, critical global health, hiv prevention

                Comments

                Comment on this article